The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

This week’s Current Climate newsletter also looks at a new funding for California’s bullet train and Norfolk Southern’s ...

Ani Dasgupta has spent a career trying to make cities fairer and the planet more livable, first as an architect in training, then as a World Bank hand in the churn of post-disaster recovery, and now ...

A microgrid’s value lies not just in its presence, but in the key design and configuration factors that determine its ...

Digital access is a strategic requirement in overseas operations. Israeli organizations are now expected to embed resilience ...

A University of South Florida researcher and a team from the Netherlands are proposing a new way to measure hurricane ...

Redington, Google, and CIMSME partner to drive digital adoption, AI, and cloud for MSMEs, helping micro businesses scale and ...

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / From the start, recycling was pitched as the low-cost, high-impact fix for the planet’s plastic problem. And everyone played along. Governments ...

TurboTenant reports starting a rental property business can generate steady income and long-term wealth, requiring market ...

The ascension of Saudi Arabia’s fintech industry is a story of transformation. Under the sweeping ambitions of Vision 2030, ...

A new rule allowing a U.S. immigration agency to scrutinize a person’s “anti-American” views when applying for a green card ...

Dr Kelechi Ohiri, discusses the country’s bold push to reform health care financing and achieve universal health coverage.